Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.

1222.5.03 Boehringer Ingelheim Investigational Site, Birmingham

1222.5.07 Boehringer Ingelheim Investigational Site, Lakewood

1222.5.14 Boehringer Ingelheim Investigational Site, Denver

1222.5.13 Boehringer Ingelheim Investigational Site, Wheat Ridge

1222.5.17 Boehringer Ingelheim Investigational Site, Wheat Ridge

1222.5.18 Boehringer Ingelheim Investigational Site, Stamford

1222.5.15 Boehringer Ingelheim Investigational Site, Panama City

1222.5.04 Boehringer Ingelheim Investigational Site, Coeur d'Alene

1222.5.22 Boehringer Ingelheim Investigational Site, Shreveport

1222.5.11 Boehringer Ingelheim Investigational Site, Reno

1222.5.24 Boehringer Ingelheim Investigational Site, New York

1222.5.12 Boehringer Ingelheim Investigational Site, Raleigh

1222.5.10 Boehringer Ingelheim Investigational Site, Medford

1222.5.05 Boehringer Ingelheim Investigational Site, Hershey

1222.5.02 Boehringer Ingelheim Investigational Site, Philadelphia

1222.5.08 Boehringer Ingelheim Investigational Site, Charleston

1222.5.19 Boehringer Ingelheim Investigational Site, Charleston

1222.5.06 Boehringer Ingelheim Investigational Site, Spartanburg

1222.5.21 Boehringer Ingelheim Investigational Site, Kileen

1222.5.01 Boehringer Ingelheim Investigational Site, San Antonio

1222.5.23 Boehringer Ingelheim Investigational Site, Richmond

1222.5.20 Boehringer Ingelheim Investigational Site, Tacoma

1222.5.039 St. Boniface General Hospital & Health Science Centre, Winnipeg

1222.5.032 Division of Respirology, Halifax

1222.5.038 Courtice Health Centre, Courtice

1222.5.037 Kingston General Hospital, Kingston

1222.5.031 Alpha Medical Research Inc., Mississauga

1222.5.034 Pulmonary Care Clinic and Research Centre, Toronto

1222.5.040 Respiratory Research Lab, Toronto

1222.5.033 Centre de Recherche Clinique -CHUS, Sherbrooke

1222.5.035 Hopital Laval, Ste-Foy

1222.5.036 Department of Respiratory Medicine, Saskatoon

1222.5.046 Boehringer Ingelheim Investigational Site, Berlin

1222.5.049 Boehringer Ingelheim Investigational Site, Berlin

1222.5.052 Boehringer Ingelheim Investigational Site, Gauting

1222.5.051 Boehringer Ingelheim Investigational Site, Großhansdorf

1222.5.047 Boehringer Ingelheim Investigational Site, Rüdersdorf

1222.5.048 Boehringer Ingelheim Investigational Site, Wiesbaden

1222.5.058 Boehringer Ingelheim Investigational Site, Almelo

1222.5.056 Boehringer Ingelheim Investigational Site, Breda

1222.5.059 Boehringer Ingelheim Investigational Site, Eindhoven

1222.5.057 Boehringer Ingelheim Investigational Site, Heerlen